ICG-Guided Photodynamic Therapy for Treatment of Retinal Capillary Abnormalities: A Pilot Study
- First Posted Date
- 2013-11-01
- Last Posted Date
- 2013-11-01
- Lead Sponsor
- Manhattan Eye, Ear & Throat Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT01974622
- Locations
- ๐บ๐ธ
Vitreous Retina Macula Consultants of New York, New York, New York, United States
Intravitreal Aflibercept Injections In The Treatment Of Pattern Dystrophy
- First Posted Date
- 2013-10-18
- Last Posted Date
- 2014-12-31
- Lead Sponsor
- Manhattan Eye, Ear & Throat Hospital
- Registration Number
- NCT01965041
- Locations
- ๐บ๐ธ
Ns/Lij Meeth, New York, New York, United States
Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave Acetate
- Conditions
- Interventions
- First Posted Date
- 2007-06-21
- Last Posted Date
- 2012-10-25
- Lead Sponsor
- Manhattan Eye, Ear & Throat Hospital
- Target Recruit Count
- 5
- Registration Number
- NCT00489840
- Locations
- ๐บ๐ธ
Manhattan Eye, ear & Throat Institute, New York, New York, United States
๐บ๐ธVitreous-Retina-Macula Consultants of New York,PC, New York, New York, United States
Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy
- Conditions
- Interventions
- First Posted Date
- 2007-05-08
- Last Posted Date
- 2012-10-25
- Lead Sponsor
- Manhattan Eye, Ear & Throat Hospital
- Target Recruit Count
- 18
- Registration Number
- NCT00470977
- Locations
- ๐บ๐ธ
Lenox Hill Hospital/Manhattan Eye, Ear & Throat Institute, New York, New York, United States
๐บ๐ธLenox Hill Hospital/Manhattan Eye Ear and Throat Institute, New York, New York, United States
Treatment of Retinal Vein Occlusion (RVO) With Open-Label Anecortave Acetate (15mg.)
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2009-02-04
- Lead Sponsor
- Manhattan Eye, Ear & Throat Hospital
- Registration Number
- NCT00211354
- Locations
- ๐บ๐ธ
Manhattan Eye, Ear & Throat Hospital, New York, New York, United States
Treatment of Idiopathic Perifoveal Telangiectasia (IPT) With Open-Label Anecortave Acetate (15mg.).
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2009-02-04
- Lead Sponsor
- Manhattan Eye, Ear & Throat Hospital
- Target Recruit Count
- 5
- Registration Number
- NCT00211328
- Locations
- ๐บ๐ธ
Manhattan Eye, Ear & Throat Hospital, New York, New York, United States
Treatment of Radiation Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg)
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2007-06-21
- Lead Sponsor
- Manhattan Eye, Ear & Throat Hospital
- Target Recruit Count
- 2
- Registration Number
- NCT00211367
- Locations
- ๐บ๐ธ
Manhattan Eye, Ear & Throat Hospital, New York, New York, United States
Treatment of Diabetic Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg)
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2007-05-08
- Lead Sponsor
- Manhattan Eye, Ear & Throat Hospital
- Registration Number
- NCT00211406
- Locations
- ๐บ๐ธ
Manhattan Eye, Ear & Throat Hospital, New York, New York, United States
Treatment of Conditions With Open Label-Anecortave Acetate Sterile Suspension ( 15mg.) Where Lesions do Not Meet Acceptable Criteria for Standard Care.
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2007-05-07
- Lead Sponsor
- Manhattan Eye, Ear & Throat Hospital
- Target Recruit Count
- 5
- Registration Number
- NCT00211484
- Locations
- ๐บ๐ธ
Manhattan Eye, Ear & Throat Hospital, New York, New York, United States
Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.).
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2007-05-07
- Lead Sponsor
- Manhattan Eye, Ear & Throat Hospital
- Registration Number
- NCT00211471
- Locations
- ๐บ๐ธ
Manhattan Eye, Ear & Throat Hospital, New York, New York, United States